Treatment of mature B-cell lymphoma/leukaemia
- Conditions
- eukaemia (acute), lymphoma (non-Hodgkin's)CancerLeukaemia
- Registration Number
- ISRCTN25173819
- Lead Sponsor
- Cancer Research UK (CRUK) (UK)
- Brief Summary
1. 2007 results in https://www.ncbi.nlm.nih.gov/pubmed/17132719 (added 25/01/2019)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 0
1. B-large cell, small non-cleaved non-Hodgkin's disease or B-cell leukaemia
2. Stages I-IV
3. Aged over 6 months and under 18 years
4. No previous chemotherapy. Emergency radiotherapy or immunotherapy is permitted
5. No congenital immunodeficiency
6. No prior organ transplantation
7. No previous malignancy of any type
8. No medical contraindications to protocol treatments
9. Patients available for a minimal follow-up of 36 months
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration